In 2023, there were 154 IPOs on the U.S. stock market.
Healthcare Dominates Top IPOs
Jin Medical emerged as the highest-performing IPO in 2023, despite facing delisting from the Nasdaq for failing to meet a listing rule requiring the firm to have at least 300 public holders.
According to an article from Benzinga, Jin Medical is a Cayman Islands holding company that owns Chinese manufacturers of wheelchairs.
Other top-performing IPOs in 2023 included healthcare names like RayzeBio, a clinical-stage radiopharmaceutical therapeutics company, and Structure Therapeutics, which focuses on “small molecule medicines”.
While four of the top 10 IPOs were in the healthcare sector, three were in financial services, two in technology, one in food and beverage, and the other in the energy sector.
IPOs That Bombed in 2023
Similarly, the majority of companies on the list of worst IPOs are from the healthcare sector. However, the list is led by the Chinese EV battery producer U Power. The company experienced highs of 1,100% at one point during its Nasdaq-listed IPO before plummeting due to regulatory restrictions in China.
Companies That Tanked the Hardest in 2023
The list of worst IPOs is led by U Power. The Chinese EV battery company experienced highs of 1,100% at one point during its Nasdaq-listed IPO before plummeting due to regulatory restrictions in China.
The list of worst performing IPOs in 2023 also includes:
Lucy Scientific Discovery, an early-stage psychotropics company
Mangoceuticals, an online retailer of erectile dysfunction treatments
Surf Air, an electric aviation company focused on regional air travel
Hanryu Holdings, which owns “Fantoo”, an online platform designed for fandom communities
The 154 IPOs on the US stock market in 2023 represented a 15% decrease compared to the 181 IPOs in 2022, and an 85% decline from the record number of 1,035 IPOs in 2021.